GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $16,716,000 | +9.4% | 400,000 | 0.0% | 11.22% | +1.3% |
| Q4 2018 | $15,284,000 | -4.9% | 400,000 | 0.0% | 11.08% | +4.0% |
| Q3 2018 | $16,068,000 | -0.3% | 400,000 | 0.0% | 10.65% | +57.2% |
| Q2 2018 | $16,124,000 | +3.2% | 400,000 | 0.0% | 6.78% | -0.3% |
| Q1 2018 | $15,628,000 | +10.1% | 400,000 | 0.0% | 6.80% | +10.1% |
| Q4 2017 | $14,188,000 | -12.6% | 400,000 | 0.0% | 6.18% | -12.8% |
| Q3 2017 | $16,240,000 | -5.8% | 400,000 | 0.0% | 7.08% | -3.4% |
| Q2 2017 | $17,248,000 | +2.3% | 400,000 | 0.0% | 7.33% | +0.6% |
| Q1 2017 | $16,864,000 | +9.5% | 400,000 | 0.0% | 7.28% | +7.7% |
| Q4 2016 | $15,404,000 | -10.7% | 400,000 | 0.0% | 6.76% | -13.6% |
| Q3 2016 | $17,252,000 | -0.5% | 400,000 | 0.0% | 7.82% | +4.4% |
| Q2 2016 | $17,336,000 | +6.9% | 400,000 | 0.0% | 7.49% | +69.5% |
| Q1 2016 | $16,220,000 | – | 400,000 | – | 4.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |